Shanghai Key Laboratory of Green Chemistry and Chemical Processes, School of Chemistry and Molecular Engineering, East China Normal University, Shanghai, 200062, China.
State Key Laboratory of Pharmaceutical Biotechnology and MOE Key Laboratory of Model Animals for Disease Study, Model Animal Research Center, Nanjing University, Nanjing, Jiangsu, 210061, China.
Nat Commun. 2017 Nov 20;8(1):1619. doi: 10.1038/s41467-017-01451-1.
Optically active spirocyclic compounds play an important role in drug discovery, and new synthetic strategies for the efficient generation of spiro stereocenters are in much demand. Here we report a catalytic enantioselective cycloaddition using spirocyclic donor-acceptor cyclopropanes as a promising approach for the generation of spiro stereocenters. A diastereo- and enantioselective [3 + 3] cycloaddition of spirocyclopropyl oxindoles with both aldonitrones and ketonitrones is developed. The key to reaction development is the activation of spirocyclopropyl oxindoles by a suitable electron-withdrawing N-protecting group. This activation approach offers the promise of a general solution to enable spirocyclopropyl oxindoles as synthons for catalytic enantioselective synthesis of spirocyclic oxindoles featuring a C3 spiro stereocenter, a prominent structural motif in drugs and pharmaceutically active compounds. This protocol also constitutes the catalytic enantioselective reaction using unactivated achiral ketonitrones to construct tetrasubstituted carbon stereocenters.
具有光学活性的螺环化合物在药物发现中起着重要作用,因此需要新的合成策略来高效地生成螺立体中心。在此,我们报告了一种使用螺环给体-受体环丙烷的催化对映选择性环加成反应,这是一种生成螺立体中心的很有前途的方法。螺环丙基氧化吲哚与醛亚胺和酮亚胺的非对映和对映选择性[3+3]环加成反应得到了发展。反应发展的关键是通过合适的吸电子 N-保护基激活螺环丙基氧化吲哚。这种激活方法有望为螺环丙基氧化吲哚作为构建具有 C3 螺立体中心的螺环氧化吲哚的催化对映选择性合成的前体提供通用解决方案,C3 螺立体中心是药物和具有药理活性的化合物中的一个重要结构基序。该方案还包括使用未活化的手性酮亚胺构建四取代碳立体中心的催化对映选择性反应。